These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15759144)

  • 1. Molecular models of protein targets from Mycobacterium tuberculosis.
    Silveira NJ; Uchôa HB; Pereira JH; Canduri F; Basso LA; Palma MS; Santos DS; de Azevedo WF
    J Mol Model; 2005 Mar; 11(2):160-6. PubMed ID: 15759144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
    Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
    Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MtbSD--a comprehensive structural database for Mycobacterium tuberculosis.
    Hassan S; Logambiga P; Raman AM; Subazini TK; Kumaraswami V; Hanna LE
    Tuberculosis (Edinb); 2011 Nov; 91(6):556-62. PubMed ID: 21880546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinase.
    Björkelid C; Bergfors T; Raichurkar AK; Mukherjee K; Malolanarasimhan K; Bandodkar B; Jones TA
    J Biol Chem; 2013 Jun; 288(25):18260-70. PubMed ID: 23661699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DBMODELING: a database applied to the study of protein targets from genome projects.
    da Silveira NJ; Bonalumi CE; Uchõa HB; Pereira JH; Canduri F; de Azevedo WF
    Cell Biochem Biophys; 2006; 44(3):366-74. PubMed ID: 16679523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis.
    Shan S; Chen X; Liu T; Zhao H; Rao Z; Lou Z
    FASEB J; 2011 May; 25(5):1577-84. PubMed ID: 21282208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikimate kinase, a protein target for drug design.
    Coracini JD; de Azevedo WF
    Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis.
    de Azevedo WF
    Curr Med Chem; 2011; 18(9):1353-66. PubMed ID: 21366529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
    Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
    J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein interaction network analysis--approach for potential drug target identification in Mycobacterium tuberculosis.
    Kushwaha SK; Shakya M
    J Theor Biol; 2010 Jan; 262(2):284-94. PubMed ID: 19833135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
    Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
    Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis.
    Mustyala KK; Malkhed V; Chittireddy VR; Vuruputuri U
    Int J Mycobacteriol; 2015 Dec; 4(4):330-6. PubMed ID: 26964817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of shikimic acid with shikimate kinase.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
    Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins with complex architecture as potential targets for drug design: a case study of Mycobacterium tuberculosis.
    Mészáros B; Tóth J; Vértessy BG; Dosztányi Z; Simon I
    PLoS Comput Biol; 2011 Jul; 7(7):e1002118. PubMed ID: 21814507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of Mycobacterium tuberculosis Rv3168: a putative aminoglycoside antibiotics resistance enzyme.
    Kim S; Nguyen CM; Kim EJ; Kim KJ
    Proteins; 2011 Oct; 79(10):2983-7. PubMed ID: 21905120
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
    Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
    PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
    Hartmann MD; Bourenkov GP; Oberschall A; Strizhov N; Bartunik HD
    J Mol Biol; 2006 Dec; 364(3):411-23. PubMed ID: 17020768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.